21st Austria weekly - Marinomed 22/05/2024 [pic1]Marinomed: Biotech AG VSE:MARI announces revenues of EUR 0.7 million recorded in the first quarter 2024. After observing record from Carragelose product sales heavily influenced by SARS-CoV-2 pandemic over past years revenue 2024 has declined to levels observed before pandemic. This decline is mostly due high inventories and return seasonality causing a drop customer demand. Due cost-conscious cash management equivalents stood at 1.9 compared 2.6 end 2023. The operating result EBIT -1.9 Q1 2023: -1.4 million loss for period amounted -2.1 million. “Although we are making constant progress working on several initiatives parallel situation remains challenging. Revenues
The demand for Smart Lighting technology is increasing due to the growing need for energy-efficient lighting solutions and the rising adoption of IoT and connected devices.
Zillertalbahn hydrogen plan dropped in favour of battery traction railwaygazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from railwaygazette.com Daily Mail and Mail on Sunday newspapers.
d&b group Appoints Melanie Stegemann as its new Vice President of Brand and Corporate Communications etnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etnow.com Daily Mail and Mail on Sunday newspapers.